Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-related Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchUnknownNCT05099094
What this trial is testing

VEGFA-targeting Gene Therapy to Treat Retinal and Choroidal Neovascularization Diseases

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular EdemaRetinal Vein Occlusion
Shanghai BDgene Co., Ltd. 3
Not applicableStudy completedNCT01918553
What this trial is testing

Cohort Study on the Age-related Macular Degeneration: Incidence and Research for Predisposing Factors

Who this might be right for
Elderly French PopulationAge-related Macular Degeneration
University Hospital, Bordeaux 516
Not applicableStudy completedNCT05441072
What this trial is testing

Validation of Bulbicam for DR- and AMD-patients

Who this might be right for
Diabetic RetinopathyAge-Related Macular Degeneration
Meddoc 64
Early research (Phase 1)Study completedNCT04151212
What this trial is testing

A Phase I Clinical Trial of BAT5906 Injection in Patients With Wet Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Bio-Thera Solutions 24
Testing effectiveness (Phase 2)Study completedNCT00531336
What this trial is testing

MAAM Study: Avastin and Macugen Versus Avastin Versus Macugen

Who this might be right for
Macular Degeneration
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery 60
Not applicableLooking for participantsNCT07382141
What this trial is testing

Early Identification of Cardivascular Damage Induced by Chemotherapy and Antineoplastic Treatments in Pediatric Age

Who this might be right for
Cardiotoxicity
IRCCS Azienda Ospedaliero-Universitaria di Bologna 400
Not applicableEnded earlyNCT00474695
What this trial is testing

Study Evaluating Genotypes Using Lucentis

Who this might be right for
Age-Related Maculopathy
University of Utah 65
Early research (Phase 1)Study completedNCT00874575
What this trial is testing

Nutritional Intervention for Age-related Muscular Function and Strength Losses

Who this might be right for
Muscle StrengthSarcopenia
Metabolic Technologies Inc. 76
Post-approval studies (Phase 4)Study completedNCT01148511
What this trial is testing

Comparison of Safety, Effectiveness and Quality of Life Outcomes Between Labeled Versus "Treat and Extend" Regimen in Turkish Patients With Choroidal Neovascularisation Due to Age-related Macular Degeneration (AMD)

Who this might be right for
Age-related Macular Degeneration
Novartis Pharmaceuticals 99
Early research (Phase 1)Study completedNCT00782093
What this trial is testing

Ascending and Parallel Group Trial to Establish the Safety, Tolerability and Pharmacokinetics Profile of Volociximab (Alpha 5 Beta 1 Integrin Antagonist) in Subjects With Neovascular Age- Related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Ophthotech Corporation 63
Post-approval studies (Phase 4)Study completedNCT00680498
What this trial is testing

Combination Lucentis and Ocular Photodynamic Therapy With Visudyne, With Evaluation-based Retreatment

Who this might be right for
Age-Related Macular Degeneration
Illinois Retina Associates 10
Not applicableLooking for participantsNCT07468877
What this trial is testing

This Clinical Trial Compares Two Phacoemulsification Systems Used in a Bilateral Cataract Surgery Subjects in Order to Study CDE and Ultrasound Time During Cataract Removal

Who this might be right for
Nuclear Sclerosis of the LensPhacoemulsification Cataract SurgeryCataract Bilateral
Nicole Fram M.D. 30
Testing effectiveness (Phase 2)UnknownNCT05187104
What this trial is testing

Treatment of Age-related Macular Degeneration Using Retinal Stem and Progenitor Cells

Who this might be right for
Age-Related Macular Degeneration
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus 20
Early research (Phase 1)Study completedNCT01661894
What this trial is testing

Effectiveness of a Brain-Computer Interface Based System for Cognitive Enhancement in the Normal Elderly

Who this might be right for
Alzheimer's DiseaseMild Cognitive ImpairmentAge-Related Cognitive Decline+1 more
Duke-NUS Graduate Medical School 82
Not applicableStudy completedNCT01103505
What this trial is testing

HOme Vision Monitoring in AREDS2 for Progression to Neovascular AMD Using the ForeseeHome Device

Who this might be right for
Age Related Macular Degeneration
Notal Vision Ltd. 1,520
Testing effectiveness (Phase 2)Study completedNCT00413829
What this trial is testing

Immediate Effects of Lucentis® in Conjunction With Photodynamic Therapy With Visudyne® in Exudative AMD(IECOMB)

Who this might be right for
Age Related Macular Degeneration
Insel Gruppe AG, University Hospital Bern 20
Not applicableStudy completedNCT02912130
What this trial is testing

Exercise and Nutrition Interventions in Age-related Sarcopenia

Who this might be right for
SarcopeniaMuscular Atrophy
Liverpool Hope University 110
Large-scale testing (Phase 3)Study completedNCT00051129
What this trial is testing

Anecortave Acetate in Subfoveal Choroidal Neovascularization (CNV) Due to Wet Age-Related Macular Degeneration (AMD)

Who this might be right for
Macular DegenerationMaculopathy, Age-RelatedAge-Related Maculopathies+2 more
Alcon Research 291
Not applicableStudy completedNCT00787319
What this trial is testing

Long-Term Non-Interventional Study (NIS) To Investigate The Safety And Effectiveness Of MACUGEN In Patients With Neovascular Age-Related Macular Degeneration Under Conditions Of Routine Clinical Practice

Who this might be right for
Age-related Macular Degeneration
Pfizer 108
Post-approval studies (Phase 4)UnknownNCT03468296
What this trial is testing

Two-week Retreatment Interval Study for Treated Age-related Macular Degeneration Refractory to Monthly Aflibercept

Who this might be right for
Neovascular Age-related Macular Degeneration
Tennessee Retina 22
Next Page